2667-0380

Journal of Clinical Virology Plus

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 244 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact244 DOIs
2

Attach ORCID iDs across 98 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact98 DOIs

DOIs for this ISSN

Showing the top 5 of 244 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Co-infection of SARS-CoV-2 and influenza viruses: A systemat… (10.1016/j.jcvp.2021.100036)
Abstract ORCID
86.62 53
2 The incidence of infectious diseases and viruses other than… (10.1016/j.jcvp.2021.100060)
Abstract ORCID
73.86 29
3 SARS-CoV-2 loads in urine, sera and stool specimens in assoc… (10.1016/j.jcvp.2021.100059)
Abstract ORCID
66.11 20
4 Next generation sequencing-based transcriptome data mining f… (10.1016/j.jcvp.2024.100194)
Abstract ORCID
55.70 12
5 Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/… (10.1016/j.jcvp.2021.100042)
Abstract ORCID
52.07 10
6 Evaluation of the genalyte maverick SARS-CoV-2 multi-antigen… (10.1016/j.jcvp.2021.100030)
Abstract ORCID
47.71 8
7 A retrospective analysis of 902 hospitalized COVID‐19 patien… (10.1016/j.jcvp.2021.100048)
Abstract ORCID
47.71 8
8 Duration of COVID-19 PCR positivity for Omicron vs earlier v… (10.1016/j.jcvp.2022.100085)
Abstract ORCID
47.71 8
9 Detection of SARS-CoV-2 VOC-Omicron using commercial sample-… (10.1016/j.jcvp.2022.100091)
Abstract ORCID
47.71 8
10 Genetic characterization of influenza A(H1N1)pdm09 virus in… (10.1016/j.jcvp.2024.100178)
Abstract ORCID
47.71 8
11 Single base mutations in the nucleocapsid gene of SARS-CoV-2… (10.1016/j.jcvp.2021.100037)
Abstract ORCID
45.15 7
12 Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA respo… (10.1016/j.jcvp.2021.100041)
Abstract ORCID
45.15 7
13 An epidemiological prospective of focal outbreak of dengue i… (10.1016/j.jcvp.2022.100063)
Abstract ORCID
45.15 7
14 Characteristics of children with confirmed SARS-CoV-2 infect… (10.1016/j.jcvp.2021.100027)
Abstract ORCID
42.25 6
15 High prevalence and prolonged shedding with enteric viruses… (10.1016/j.jcvp.2021.100046)
Abstract ORCID
42.25 6
16 Interpretation of single target positivity among SARS-CoV-2… (10.1016/j.jcvp.2021.100021)
Abstract ORCID
38.91 5
17 Evaluation of alternative RNA extraction methods for detecti… (10.1016/j.jcvp.2021.100032)
Abstract ORCID
38.91 5
18 Sensitivity of SARS-CoV-2 antibody tests with late convalesc… (10.1016/j.jcvp.2021.100038)
Abstract ORCID
38.91 5
19 Clinical and virological characteristics of patients during… (10.1016/j.jcvp.2021.100043)
Abstract ORCID
38.91 5
20 Nosocomial infections amongst critically ill COVID-19 patien… (10.1016/j.jcvp.2021.100054)
Abstract ORCID
38.91 5
21 Fast and reliable real life data on COVID-19 triaging with I… (10.1016/j.jcvp.2022.100065)
Abstract ORCID
38.91 5
22 Clinical comparison and agreement of PCR, antigen, and viral… (10.1016/j.jcvp.2022.100099)
Abstract ORCID
38.91 5
23 Emergence and evolution of SARS-CoV-2 genetic variants durin… (10.1016/j.jcvp.2022.100104)
Abstract ORCID
38.91 5
24 Differential platelet receptor expression for viral capture… (10.1016/j.jcvp.2021.100039)
Abstract ORCID
34.95 4
25 Hantavirus infection with pulmonary symptoms in north centra… (10.1016/j.jcvp.2021.100052)
Abstract ORCID
34.95 4
26 Evaluation of a novel direct RT-LAMP assay for the detection… (10.1016/j.jcvp.2022.100074)
Abstract ORCID
34.95 4
27 Evaluation of the DiaSorin LIAISON SARS-CoV-2 antigen assay… (10.1016/j.jcvp.2022.100095)
Abstract ORCID
34.95 4
28 Reverse transcription-loop-mediated isothermal amplification… (10.1016/j.jcvp.2023.100134)
Abstract ORCID
34.95 4
29 Analytical and clinical performances of seven direct detecti… (10.1016/j.jcvp.2023.100138)
Abstract ORCID
34.95 4
30 Measles surveillance: Lessons from the COVID-19 pandemic (10.1016/j.jcvp.2023.100141)
Abstract ORCID
34.95 4
31 Unique evidence of atypical lymphocytes and flower cells in… (10.1016/j.jcvp.2023.100155)
Abstract ORCID
34.95 4
32 Efficacy and safety of intravenous peramivir versus oral ose… (10.1016/j.jcvp.2024.100179)
Abstract ORCID
34.95 4
33 Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV… (10.1016/j.jcvp.2021.100014)
Abstract
31.97 18
34 Field performance evaluation of the PanBio rapid SARS-CoV-2… (10.1016/j.jcvp.2021.100013)
Abstract
31.38 17
35 Early detection of community acquired of SARS-CoV-2 lineage… (10.1016/j.jcvp.2021.100029)
Abstract ORCID
30.10 3
36 Regional differences in vaccine uptake and serological respo… (10.1016/j.jcvp.2021.100034)
Abstract ORCID
30.10 3
37 Epidemiological and clinical characteristics of children wit… (10.1016/j.jcvp.2021.100049)
Abstract ORCID
30.10 3
38 Epstein- Barr viral load in exfoliated cells of oral squamou… (10.1016/j.jcvp.2021.100051)
Abstract ORCID
30.10 3
39 Borderline and weakly positive antibody levels against the S… (10.1016/j.jcvp.2021.100058)
Abstract ORCID
30.10 3
40 Humoral cross-reactivity towards SARS-CoV-2 in young childre… (10.1016/j.jcvp.2022.100061)
Abstract ORCID
30.10 3
41 Diagnosis of HIV infection using mass community rapid testin… (10.1016/j.jcvp.2022.100064)
Abstract ORCID
30.10 3
42 Factors associated with death and ICU referral among COVID-1… (10.1016/j.jcvp.2022.100068)
Abstract ORCID
30.10 3
43 Development and validation of an enzyme-linked immunoassay k… (10.1016/j.jcvp.2022.100101)
Abstract
30.10 15
44 Improvements in metagenomic virus detection by simple pretre… (10.1016/j.jcvp.2022.100120)
Abstract ORCID
30.10 3
45 Environmental surveillance of SARS-CoV-2 for outbreak detect… (10.1016/j.jcvp.2024.100199)
Abstract ORCID
30.10 3
46 Dengue virus proteins: Dual drivers of pathogenesis and vacc… (10.1016/j.jcvp.2025.100227)
Abstract ORCID
30.10 3
47 Diagnostic utility and validation of a newly developed real… (10.1016/j.jcvp.2022.100081)
Abstract
29.40 14
48 From Delta to Omicron SARS-CoV-2 variant: Switch to saliva s… (10.1016/j.jcvp.2022.100090)
Abstract
29.40 14
49 High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust… (10.1016/j.jcvp.2023.100156)
Abstract
29.40 14
50 Comparison of two nucleic acid amplification tests (NAATs) a… (10.1016/j.jcvp.2021.100011)
Abstract
26.98 11